BAY CITY CAPITAL LLC 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Dec 1, 2020
Insider Transaction Report
Form 4
BAY CITY CAPITAL LLC
Director10% Owner
Transactions
- Other
Common Stock
2020-12-01−43,537→ 2,310,521 total(indirect: See Footnotes)
Footnotes (2)
- [F1]Represents a transfer, without the payment of any consideration, to an affiliate.
- [F2]Includes 2,260,791 shares of common stock held by Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and 49,730 shares of common stock held by Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV"). Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Fund IV and Co-Investment IV are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.